Vectus Biosystems (VBS) Short Interest
Vectus Biosystems (ASX:VBS) had 0.00% of shares reported as short positions as of 10 Nov 2025, representing 1,054 shares. Vectus Biosystems operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Vectus Biosystems
Vectus Biosystems is a medical research and development company focused on developing therapies for fibrosis and hypertension. Their lead drug candidate, VB0004, is undergoing Phase I human trials as an anti-fibrotic treatment. The company intends to remain a research and development entity, licensing its current and future technologies.
Short position
Vectus Biosystems (ASX:VBS) has 0.00% of its shares on issue reported as short positions as of 10 Nov 2025, or about 1,054 shares. VBS is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 37, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4VBS intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Vectus Biosystems
Latest VBS news
All news- Date of 2026 Annual General Meeting
asx · 8 Sept 2026
- Change of Director's Interest Notice - MS
asx · 3 Sept 2026
- Cleansing Notice
asx · 1 Sept 2026
- Application for quotation of securities - VBS
asx · 1 Sept 2026
- Full Year Statutory Accounts
asx · 30 Aug 2026
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss VBS
Start a research thread or post the first pulse update